Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | -92.86% | 0.00% |
Mar. 12 | Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products | MT |
Oct. 26 | Motion For Case Conversion Approved for ViewRay, Inc. | CI |
Financials (USD)
Sales 2021 | 70.12M | Sales 2022 | 102M | Capitalization | 813M |
---|---|---|---|---|---|
Net income 2021 | -110M | Net income 2022 | -107M | EV / Sales 2021 | 11.8 x |
Net cash position 2021 | 150M | Net cash position 2022 | 49.56M | EV / Sales 2022 | 7.47 x |
P/E ratio 2021 |
-8.24
x | P/E ratio 2022 |
-7.54
x | Employees | 295 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 91.76% |
Latest transcript on ViewRay, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Paul Ziegler
CEO | Chief Executive Officer | 52 | 18-12-31 |
James F. Dempsey
FOU | Founder | 53 | 03-12-31 |
Cassie Mahar
DFI | Director of Finance/CFO | 38 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 21-06-10 |
B. Johnson
BRD | Director/Board Member | 72 | 20-04-13 |
Caley Castelein
BRD | Director/Board Member | 53 | 07-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 17 M€ | -0.46% | ||
0.02% | 464 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 0.000001 | 0.00% | 8,000 |
24-03-22 | 0.000001 | 0.00% | 3,107 |
24-03-21 | 0.000001 | -92.86% | 2,491 |
24-03-20 | 0.000014 | +1,300.00% | 74,200 |
Delayed Quote OTC Markets, March 27, 2024 at 09:39 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 183 | |
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.15% | 46.84B | |
+4.66% | 42.64B | |
+17.58% | 41.4B |